Results 21 to 30 of about 462,380 (329)

Relation of hyperlipidemia in serum and loss of high density lipoproteins in urine in the nephrotic syndrome [PDF]

, 1987
The mechanism leading to hyperlipidemia in the nephrotic syndrome is not fully understood but may be related in part to loss of high density lipoproteins in the urine of patients with nephrosis.
Appel, Baxter, Baxter, Chopra, De Mendoza, Eggstein, Felts, Gherardi, Gherardi, Havel, Jüngst, Jüngst, Kashyap, Klahr, Lopes-Virella, Newmark, Ohta, Röschlau, Sachs, Sata, Tamm, Wada, Weichselbaum   +22 more
core   +1 more source

Male–female variability in the dietary cholesterol-induced hyperlipoproteinemia of cynomolgus monkeys (Macaca fascicularis).

Journal of Lipid Research, 1978
The characteristics of dietary cholesterol-induced hyperlipoproteinemia were studied in adult Macaca fascicularis to determine if significant male–female differences could be identified.
L L Rudel, L L Pitts, 2nd
doaj   +1 more source

Blood rheology, cardiovascular risk factors, and cardiovascular disease: The West of Scotland Coronary Prevention Study [PDF]

, 2000
The West of Scotland Coronary Prevention Study (WOSCOPS) showed that pravastatin reduced the risk of coronary heart disease (CHD) events in 6,595 middle-aged hypercholesterolaemic men aged 45-64 years without prior myocardial infarction followed for an ...
Ann Rumley, Christopher Packard, Gordon Lowe, Ian Ford, James Shepherd, John Norrie, null null, Peter Macfarlane, Stuart Cobbe   +8 more
core   +1 more source

Lipoprotein lipase-facilitated uptake of LDL is mediated by the LDL receptor [PDF]

Journal of Lipid Research, 2007
LPL mediates the uptake of lipoproteins into different cell types independent of its catalytic activity. The mechanism of this process and its physiological relevance are not clear. Taking into account the importance of the endothelial barrier for lipoprotein uptake, in vitro studies with primary aortic endothelial cells from wild-type and low density ...
Britta Loeffler, Joerg Heeren, Mareike Blaeser, Herbert Radner, Daniel Kayser, Birol Aydin, Martin Merkel   +6 more
openaire   +3 more sources

The effect of hypertension, diabetes, and smoking on the levels of some biochemical parameters in chronic renal failure patients

Tikrit Journal of Pure Science, 2019
This study has been acomblished between December 2016 and September  2017 which included 70 patients with chronic renal failure who attended at Al-yarmuke teaching hospital in Baghdad with25 healthy individual as control.
Noor H. Ali, Firas T. Maher, Mohammad M. F. Al-Halbosiy   +2 more
doaj   +1 more source

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles. [PDF]

, 2017
Treatment of dyslipidemia patients with lipid-lowering drugs leads to a significant reduction in low-density lipoproteins (LDL) level and a low to moderate level of increase in high-density lipoprotein (HDL) cholesterol in plasma.
Alderete, Benjamin, Amento, Edward P, Kong, Raymond, Liu, David, Lundry, Jason, Madasamy, Shanmugavel, Robinson, J Paul, Wu, Alan HB   +7 more
core   +1 more source

Liver Transplantation to Provide Low-Density-Lipoprotein Receptors and Lower Plasma Cholesterol in a Child with Homozygous Familial Hypercholesterolemia [PDF]

, 1984
A six-year-old girl with severe hypercholesterolemia and atherosclerosis had two defective genes at the low-density-lipoprotein (LDL) receptor locus, as determined by biochemical studies of cultured fibroblasts.
Cummings, David W. Bilheimer, Goldstein, Joseph L. Goldstein, Michael S. Brown, Pittman, Schneider, Schneider, Scott M. Grundy, Thomas E. Starzl   +9 more
core   +1 more source

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM.

Clinical Chemistry, 2018
BACKGROUND The European Atherosclerosis Society-European Federation of Clinical Chemistry and Laboratory Medicine Consensus Panel aims to provide recommendations to optimize atherogenic lipoprotein quantification for cardiovascular risk management ...
M. Langlois, M. Chapman, C. Cobbaert, S. Mora, A. Remaley, E. Ros, G. Watts, J. Borén, H. Baum, E. Bruckert, A. Catapano, O. Descamps, A. von Eckardstein, P. Kamstrup, G. Kolovou, F. Kronenberg, A. Langsted, K. Pulkki, N. Rifai, G. Sypniewska, O. Wiklund, B. Nordestgaard   +21 more
semanticscholar   +1 more source

Effect of human plasma lipoproteins on prostacyclin production by cultured endothelial cells.

Journal of Lipid Research, 1985
Prostacyclin (PGI2) production by bovine aortic or human umbilical vein endothelial cells increased when either human high density lipoproteins3 (HDL3) or low density lipoproteins (LDL) were added to a serum-free culture medium. At low concentrations and
A A Spector, A M Scanu, T L Kaduce, P H Figard, G M Fless, R L Czervionke   +5 more
doaj   +1 more source

Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B. [PDF]

, 1992
We have reported that transgenic mice overexpressing rat apo E shows marked reduction of plasma cholesterol and triglyceride levels due to the disappearance of VLDL and LDL.
Gotoda Takanari, Harada Kenji, Katsuki Motoya, Shimada Masako, Shimano Hitoshi, Yamada Nobuhiro, Yamamoto Koji, Yazaki Yoshio, 山田 信博   +8 more
core   +1 more source